1. Home/
  2. Compounds/
  3. Bicalutamide



SourcesNames Used
GDSC1000, FIMMBicalutamide
PharmacoGx Bicalutamide

External IDs

Smiles: CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
Pubchem: 2375

Annotated Targets


Cell lines tested with Bicalutamide

1043 cell lines have been tested with this compound, using data from 2 dataset(s).
201T lung GDSC10001
22RV1 prostate GDSC10002
23132-87 stomach GDSC10002
42-MG-BA central nervous system GDSC10002
451Lu skin GDSC10002
5637 urinary tract GDSC10002
639-V urinary tract GDSC10002
647-V urinary tract GDSC10002
697 haematopoietic and lymphoid tissue GDSC10002
769-P kidney GDSC10002
Download CSV
Download Data as CSV

Top molecular features associated with response to Bicalutamide

Feature TypeStandardized
Nominal ANOVA
mRNA TGFBR2 GDSC1000 AAC 0.18 4e-07
mRNA DKK1 GDSC1000 AAC 0.18 3e-06
mRNA FEZF2 GDSC1000 AAC 0.15 5e-06
mRNA ECM2 GDSC1000 AAC 0.15 2e-05
mRNA PLAU GDSC1000 AAC 0.17 3e-05
mRNA TRIM24 GDSC1000 AAC -0.14 4e-05
mRNA FOSL1 GDSC1000 AAC 0.15 4e-05
mRNA TNKS FIMM AAC 0.63 4e-05
mRNA UNC80 GDSC1000 AAC -0.14 5e-05
mRNA HRH1 GDSC1000 AAC 0.15 5e-05
Download CSV